Benjamin Halladay - 05 Oct 2026 Form 4 Insider Report for ACHIEVE LIFE SCIENCES, INC. (ACHV)

Reporting relationship: Chief Financial Officer
Issuer ticker: ACHV
Reported as of: 05 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Oct 2026, 16:15:13 UTC
Prior SEC filing: 13 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Erik Atkisson as attorney-in-fact

Key filing fact

Benjamin Halladay filed Form 4 for ACHIEVE LIFE SCIENCES, INC. (ACHV) on 06 Oct 2026.

Key facts

This page summarizes Benjamin Halladay's Form 4 filing for ACHIEVE LIFE SCIENCES, INC. (ACHV).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 06 Oct 2026, 16:15.

Change

Previous filing in this sequence was filed on 13 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001953943 Primary reporting owner

Halladay Benjamin

Relationship: Chief Financial Officer
Address: C/O ACHIEVE LIFE SCIENCES, INC., 22722 29TH DR. SE, SUITE 100, BOTHELL
Signature: /s/ Erik Atkisson as attorney-in-fact
Signature date: 06 Oct 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACHV transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +200,000
Change %
Price: $0.000000^*
Shares after: 200,000
Date: 05 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 200,000
Exercise price: $7.01
Footnotes: F1

ACHV transaction Derivative

Restricted Stock Unit (RSU)

Award

Transaction value
Shares: +200,000
Change %
Price: $0.000000^*
Shares after: 200,000
Date: 05 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 200,000
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This option will vest as to 1/4 of the total award on the first anniversary of October 5, 2026, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Footnote F2

Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement.

Footnote F3

The RSUs will vest as to 1/4 of the total award on each of October 5, 2027, October 5, 2028, October 5, 2029 and October 5, 2030 subject to the Reporting Person's provision of service to the Issuer on each vesting date.